Cardiovascular Update: AI Predicts Cardiac Arrest, Stroke Recovery Device, New Heart Patch and More
From AI-powered predictions to next-gen heart patches, today’s update dives into 10 ground-breaking developments in cardiovascular health and innovation. Whether you’re a healthcare professional, researcher, or simply passionate about heart health, these stories will keep you ahead of the curve.
📌 In This Episode:
📱 Digital heart health program significantly lowers blood pressure in menopausal women, with women showing greater improvements than men over 12 months.
🤖 Johns Hopkins develops a deep learning AI model predicting sudden cardiac arrest with up to 89 percent accuracy in high-risk HCM patients.
🦾 Wearable device restores movement in stroke survivors by reinforcing neural pathways.
🎈 First patients enrolled in a trial testing sirolimus-coated balloons for small coronary vessels, potentially replacing metal stents.
🇯🇵 Japanese registry data show TEER cuts risk of death or heart failure hospitalization by 35 percent in AFMR patients.
✂️ CMS grants new technology payment boost for ShortCut leaflet-splitting device, offering hospitals up to $9,750 additional reimbursement per case.
💉 VictORION-INTERVENTION trial launches to test twice-yearly inclisiran for LDL management post-revascularization.
🩹 Next-gen heart patch integrates advanced materials and living cells to repair damaged heart tissue.
⚠️ Pregabalin linked to a 48 percent higher risk of heart failure in seniors compared to gabapentin.
❤️🩹 Bivacor total artificial heart system joins FDA fast-track program for accelerated development.
📢 Stay Ahead in Cardiovascular Research!
✅ Like, share, and subscribe for weekly updates on heart failure, AFib, stroke, and more
#Cardiology #HeartHealth #CardiovascularResearch #MedicalInnovation #StrokeRecovery #ArtificialHeart #BloodPressure #HeartFailure #AIinHealthcare #ClinicalTrials